Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling

Circulation Research

Volumn 121, Issue 1, 2017, Pages 56-70

  Mollenhauer, Martin ^a   Friedrichs, Kai ^a   Lange, Max ^a   Gesenberg, Jan ^a   Remane, Lisa ^a   Kerkenpaß, Christina ^a   Krause, Jenny ^b   Schneider, Johanna ^a   Ravekes, Thorben ^a   Maass, Martina ^a   Halbach, Marcel ^a   Peinkofer, Gabriel ^a   Saric, Tomo ^a   Mehrkens, Dennis ^a   Adam, Matti ^a   Deuschl, Florian G ^b   Lau, Denise ^b   Geertz, Birgit ^b   Manchanda, Kashish ^a   Eschenhagen, Thomas ^b   Kubala, Lukas ^c,d   Rudolph, Tanja K ^a   Wu, Yuping ^e   Tang, W H Wilson ^f   Hazen, Stanley L ^f   Baldus, Stephan ^a   Klinke, Anna ^a,d   Rudolph, Volker ^a   more..

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^e CLEVELAND STATE UNIVERSITY   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Connexin 43; fibrosis; infarction; inflammation; myocardial ischemia; tachycardia

Indexed keywords

ACETYLSALICYLIC ACID; BARIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD11B ANTIGEN; CD18 ANTIGEN; COLLAGEN; CONNEXIN 43; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTEGRIN; ISOPRENALINE; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; RECOMBINANT ENZYME; RECOMBINANT MYELOPEROXIDASE; TETRODOTOXIN; UNCLASSIFIED DRUG; PEROXIDASE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL TRANSDIFFERENTIATION; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; ELECTROCARDIOGRAPHY; ENZYMATIC DEGRADATION; ENZYME BLOOD LEVEL; EX VIVO STUDY; FEMALE; HEART FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE; HEART VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; MEDIATOR; MIDDLE AGED; MOUSE; MYOFIBROBLAST; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION STATE; PLASMA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROVOCATION TEST; SUDDEN CARDIAC DEATH; TELEMETRY; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; HEART ARRHYTHMIA; KNOCKOUT MOUSE; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELLS, CULTURED; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; PEROXIDASE; VENTRICULAR REMODELING;

EID: 85017418144     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.310870     Document Type: Article

References (35)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114:e385-e484.
2. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther. 2006;111:16-26. doi: 10.1016/j. pharmthera.2005.06.023.
3. Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 2000;275:37524-37532.
4. Vasilyev N, Williams T, Brennan ML, Unzek S, Zhou X, Heinecke JW, Spitz DR, Topol EJ, Hazen SL, Penn MS. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation. 2005;112:2812-2820. doi: 10.1161/ CIRCULATIONAHA.105.542340.
5. Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med. 2003;197:615-624.
6. Rudolph V, Andrié RP, Rudolph TK, et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med. 2010;16:470-474. doi: 10.1038/nm.2124.
7. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 2006;113:2919-2928. doi: 10.1161/CIRCULATIONAHA. 106.612960.
8. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 2001;276:41279-41287. doi: 10.1074/ jbc.M106958200.
9. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest. 2005;115:2305-2315. doi: 10.1172/JCI26381.
10. de Jong S, van Veen TA, van Rijen HV, de Bakker JM. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2011;57:630-638. doi: 10.1097/ FJC.0b013e318207a35f.
11. Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, Lim LL, Shi W, Hazen SL, Jacob JS, Crowley JR, Heinecke JW, Lusis AJ. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest. 2001;107:419-430. doi: 10.1172/JCI8797.
12. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN. A novel role for the beta 2 integrin CD11b/ CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996;5:653-666.
13. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature. 2007;450:819-824. doi: 10.1038/nature06321.
14. Vettel C, Lindner M, Dewenter M, et al. Phosphodiesterase 2 protects against catecholamine-induced arrhythmia and preserves contractile function after myocardial infarction. Circ Res. 2017;120:120-132. doi: 10.1161/CIRCRESAHA.116.310069.
15. Schrickel JW, Brixius K, Herr C, et al. Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res. 2007;76:257-268. doi: 10.1016/j. cardiores.2007.07.001.
16. Ivanyuk D, Budash G, Zheng Y, Gaspar JA, Chaudhari U, Fatima A, Bahmanpour S, Grin VK, Popandopulo AG, Sachinidis A, Hescheler J, Šarí T. Ascorbic acid-induced cardiac differentiation of murine pluripotent stem cells: transcriptional profiling and effect of a small molecule synergist of Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 2015;36:810-830. doi: 10.1159/000430140.
17. Halbach M, Pillekamp F, Brockmeier K, Hescheler J, Müller-Ehmsen J, Reppel M. Ventricular slices of adult mouse hearts - a new multicellular in vitro model for electrophysiological studies. Cell Physiol Biochem. 2006;18:1-8. doi: 10.1159/000095132.
18. Neyton J, Miller C. Potassium blocks barium permeation through a calcium-activated potassium channel. J Gen Physiol. 1988;92:549-567.
19. Lee CH, Ruben PC. Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin. Channels. 2008;2:407-412.
20. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010;7:30-37. doi: 10.1038/nrcardio.2009.199.
21. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793-2867. doi: 10.1093/eurheartj/ehv316.
22. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med. 2011;17:1391-1401. doi: 10.1038/nm.2507.
23. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-497. doi: 10.1016/j.cardiores.2003.10.011.
24. Baxter GF. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol. 2002;97:268-275. doi: 10.1007/s00395-002-0366-7.
25. van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, de Bakker JM. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation. 2004;109:1048-1055. doi: 10.1161/01.CIR.0000117402.70689.75.
26. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res. 2006;69:604-613. doi: 10.1016/j. cardiores.2005.10.002.
27. Midwinter RG, Vissers MC, Winterbourn CC. Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch Biochem Biophys. 2001;394:13-20. doi: 10.1006/abbi.2001.2530.
28. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev. 1999;79:917-1017.
29. Betsuyaku T, Kanno S, Lerner DL, Schuessler RB, Saffitz JE, Yamada KA. Spontaneous and inducible ventricular arrhythmias after myocardial infarction in mice. Cardiovasc Pathol. 2004;13:156-164. doi: 10.1016/ S1054-8807(03)00152-2.
30. Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, Berul CI. Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol. 2001;96:237-250.
31. Cascio WE, Yang H, Muller-Borer BJ, Johnson TA. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation. J Electrocardiol. 2005;38:55-59. doi: 10.1016/j. jelectrocard.2005.06.019.
32. Danik SB, Rosner G, Lader J, Gutstein DE, Fishman GI, Morley GE. Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts. FASEB J. 2008;22:1204-1212. doi: 10.1096/fj.07-8974com.
33. Greener ID, Sasano T, Wan X, Igarashi T, Strom M, Rosenbaum DS, Donahue JK. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. J Am Coll Cardiol. 2012;60:1103-1110. doi: 10.1016/j.jacc.2012.04.042.
34. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brümmer J, Rudolph V, Münzel T, Heitzer T, Meinertz T, Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA. 2005;102:431-436. doi: 10.1073/pnas.0405193102.
35. Klinke A, Nussbaum C, Kubala L, et al. Myeloperoxidase attracts neutrophils by physical forces. Blood. 2011;117:1350-1358. doi: 10.1182/ blood-2010-05-284513.